DXY, EUR/USD, USD/JPY, GBP/USD, AUD/USD, USD/CAD
HELIOS AND MATHESON ANALYTICS INC - COMMON STOCK, GROWLIFE INC., SPDR S&P 500, ADVANCED MICRO DEVICES, INC. - COMMON STOCK, BANK OF AMERICA CORPORATION COMMON STOCK, GENERAL ELECTRIC COMPANY COMMON STOCK
S&P 500, Nasdaq Composite, Dow 30, Nikkei 225, DAX Index, FTSE 100
Gold, Silver, Crude Oil, Natural Gas, Corn, Bitcoin
BTC/USD, ETH/USD, BCH/USD, XRP/USD, LTC/USD, ETC/USD
US 10Y, Euro Bund, Germany 10Y, Japan 10Y Yield, UK 10Y, India 10Y
Gold, Brent Oil, Crude Oil, CFDs on Natural Gas, Palladium, Silver
Warning: High risk pharmaceutical company. I was early in my last chart in January.
Chart looks more promising to me now. The company is developing non opioid treatments for joint pain, depression, and Alzheimer's disease. Pipeline (see ling below) is in clinical trials. If trials fail often get large drops in price and vice versa. With the opioid crisis IF these ...
ON WATCH FOR BREAKOUT HERE
VOLUME COMING IN
Proffesional activity. Looking for BUY
Possible double bottom. Watch if holds here.
See “the gold bags” post:
Cash: $41 Million (cash runway into the second quarter of 2019)
Phase 3 CREATE-1 trial of AXS-02 in CRPS, interim efficacy analysis (late December 2017 to early January 2018)
•Phase 3 COAST-1 trial of AXS-02 in knee OA associated with BMLs, interim analysis (late December 2017 to early January 2018)
•Phase 3 STRIDE-1 trial of AXS-05 in TRD, top-line data (1H ...
Current share price is testing the upward trending lower resistance line. As the lower resistance line crosses the $5 inflection line we could expect major movement ahead of the Q42017/Q12018 FDA catalysts.
Pushing down against the lower resistance line. Buy ahead of upcoming PDUFA catalyst
Just watching this one unfold in a monster...
Something's up. Not sure why, but technicals turning into a perfect storm upward ...
... and plenty of catalysts ahead for long-time investors too :D
Might be big moves ahead ...
1. I believe I see some bullish signs in the sector in general (IBB) and I want to get some exposure.
2. My friend who's doing fundamental analysis of biotech stocks, told me to look at this stock. He says they have enough money to sustain themselves for a while and some potential price catalysts in the not so distant future.
3. The chart looks to me like it ...
AXSM is as of lately recruiting heavy hitter Executives that are extremely experienced and successful in the field of commercialisation and take-over, which seems to be the next step here.
Apart from great Intitutional Holdings, Insider Holdings and cash at hand (good to go until Q1 2019), quite some catalysts are around the corner.
Oh, and chart lookes great too ;)
Stop - 3.72
Target - 4.29
AXSM is a Pharma company and is discounted over 40% from its high. The stock looks to break out of its consolidation phase. MACD looks positive, Boiling Band(BB) looks impressive, and what stands out is the way stock price has crossed 50 day MA and 100 Day MA. The next few days will give a clear indication of its positive moment. However, the stock looks like its ...